<html xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type  content="text/html; charset=UFT-8" ><meta name=ProgId  content=Word.Document ><meta name=Generator  content="Microsoft Word 14" ><meta name=Originator  content="Microsoft Word 14" ><link rel=File-List  href="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/filelist.xml" ><title></title><!--[if gte mso 9]><xml><o:DocumentProperties><o:Author>DAVE</o:Author><o:LastAuthor>独自1388757202</o:LastAuthor><o:Revision>1</o:Revision><o:Pages>10</o:Pages><o:Characters>24433</o:Characters><o:Lines>184</o:Lines><o:Paragraphs>51</o:Paragraphs></o:DocumentProperties><o:CustomDocumentProperties><o:KSOProductBuildVer dt:dt="string" >2052-12.1.0.18608</o:KSOProductBuildVer><o:ICV dt:dt="string" >92CA94222FF5454A80E7B3A97566FBCB_13</o:ICV></o:CustomDocumentProperties></xml><![endif]--><!--[if gte mso 9]><xml><o:OfficeDocumentSettings></o:OfficeDocumentSettings></xml><![endif]--><!--[if gte mso 9]><xml><w:WordDocument><w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel><w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEvery><w:DisplayVerticalDrawingGridEvery>2</w:DisplayVerticalDrawingGridEvery><w:DocumentKind>DocumentNotSpecified</w:DocumentKind><w:DrawingGridVerticalSpacing>7.8 磅</w:DrawingGridVerticalSpacing><w:View>Web</w:View><w:Compatibility><w:AdjustLineHeightInTable/><w:DontGrowAutofit/><w:BalanceSingleByteDoubleByteWidth/><w:DoNotExpandShiftReturn/><w:UseFELayout/></w:Compatibility><w:Zoom>0</w:Zoom></w:WordDocument></xml><![endif]--><!--[if gte mso 9]><xml><w:LatentStyles DefLockedState="false"  DefUnhideWhenUsed="true"  DefSemiHidden="true"  DefQFormat="false"  DefPriority="99"  LatentStyleCount="260" >
<w:LsdException Locked="false"  Priority="0"  SemiHidden="false"  UnhideWhenUsed="false"  QFormat="true"  Name="Normal" ></w:LsdException>
<w:LsdException Locked="false"  Priority="9"  SemiHidden="false"  UnhideWhenUsed="false"  QFormat="true"  Name="heading 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="9"  SemiHidden="false"  QFormat="true"  Name="heading 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="9"  SemiHidden="false"  QFormat="true"  Name="heading 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="9"  SemiHidden="false"  QFormat="true"  Name="heading 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="9"  SemiHidden="false"  QFormat="true"  Name="heading 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="9"  SemiHidden="false"  QFormat="true"  Name="heading 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="9"  SemiHidden="false"  QFormat="true"  Name="heading 7" ></w:LsdException>
<w:LsdException Locked="false"  Priority="9"  SemiHidden="false"  QFormat="true"  Name="heading 8" ></w:LsdException>
<w:LsdException Locked="false"  Priority="9"  SemiHidden="false"  QFormat="true"  Name="heading 9" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="index 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="index 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="index 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="index 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="index 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="index 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="index 7" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="index 8" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="index 9" ></w:LsdException>
<w:LsdException Locked="false"  Priority="39"  SemiHidden="false"  Name="toc 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="39"  SemiHidden="false"  Name="toc 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="39"  SemiHidden="false"  Name="toc 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="39"  SemiHidden="false"  Name="toc 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="39"  SemiHidden="false"  Name="toc 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="39"  SemiHidden="false"  Name="toc 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="39"  SemiHidden="false"  Name="toc 7" ></w:LsdException>
<w:LsdException Locked="false"  Priority="39"  SemiHidden="false"  Name="toc 8" ></w:LsdException>
<w:LsdException Locked="false"  Priority="39"  SemiHidden="false"  Name="toc 9" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Normal Indent" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="footnote text" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  QFormat="true"  Name="annotation text" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  QFormat="true"  Name="header" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  QFormat="true"  Name="footer" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="index heading" ></w:LsdException>
<w:LsdException Locked="false"  Priority="35"  SemiHidden="false"  QFormat="true"  Name="caption" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="table of figures" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="envelope address" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="envelope return" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="footnote reference" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  QFormat="true"  Name="annotation reference" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="line number" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="page number" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="endnote reference" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="endnote text" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="table of authorities" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="macro" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="toa heading" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Bullet" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Number" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Bullet 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Bullet 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Bullet 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Bullet 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Number 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Number 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Number 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Number 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="10"  SemiHidden="false"  UnhideWhenUsed="false"  QFormat="true"  Name="Title" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Closing" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Signature" ></w:LsdException>
<w:LsdException Locked="false"  Priority="1"  SemiHidden="false"  QFormat="true"  Name="Default Paragraph Font" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Body Text" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Body Text Indent" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Continue" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Continue 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Continue 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Continue 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="List Continue 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Message Header" ></w:LsdException>
<w:LsdException Locked="false"  Priority="11"  SemiHidden="false"  UnhideWhenUsed="false"  QFormat="true"  Name="Subtitle" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Salutation" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Date" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Body Text First Indent" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Body Text First Indent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Note Heading" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Body Text 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Body Text 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Body Text Indent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Body Text Indent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Block Text" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  QFormat="true"  Name="Hyperlink" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  QFormat="true"  Name="FollowedHyperlink" ></w:LsdException>
<w:LsdException Locked="false"  Priority="22"  SemiHidden="false"  UnhideWhenUsed="false"  QFormat="true"  Name="Strong" ></w:LsdException>
<w:LsdException Locked="false"  Priority="20"  SemiHidden="false"  UnhideWhenUsed="false"  QFormat="true"  Name="Emphasis" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Document Map" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Plain Text" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="E-mail Signature" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Normal (Web)" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="HTML Acronym" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="HTML Address" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="HTML Cite" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="HTML Code" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="HTML Definition" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="HTML Keyboard" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="HTML Preformatted" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="HTML Sample" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="HTML Typewriter" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="HTML Variable" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  QFormat="true"  Name="Normal Table" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  QFormat="true"  Name="annotation subject" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="No List" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="1 / a / i" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="1 / 1.1 / 1.1.1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Article / Section" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Simple 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Simple 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Simple 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Classic 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Classic 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Classic 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Classic 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Colorful 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Colorful 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Colorful 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Columns 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Columns 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Columns 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Columns 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Columns 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Grid 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Grid 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Grid 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Grid 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Grid 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Grid 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Grid 7" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Grid 8" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table List 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table List 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table List 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table List 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table List 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table List 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table List 7" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table List 8" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table 3D effects 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table 3D effects 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table 3D effects 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Contemporary" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Elegant" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Professional" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Subtle 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Subtle 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Web 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Web 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Web 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  QFormat="true"  Name="Balloon Text" ></w:LsdException>
<w:LsdException Locked="false"  Priority="39"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Table Grid" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Table Theme" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Placeholder Text" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="No Spacing" ></w:LsdException>
<w:LsdException Locked="false"  Priority="60"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Shading" ></w:LsdException>
<w:LsdException Locked="false"  Priority="61"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light List" ></w:LsdException>
<w:LsdException Locked="false"  Priority="62"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Grid" ></w:LsdException>
<w:LsdException Locked="false"  Priority="63"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="64"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="65"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="66"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="67"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="68"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="69"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="70"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Dark List" ></w:LsdException>
<w:LsdException Locked="false"  Priority="71"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Shading" ></w:LsdException>
<w:LsdException Locked="false"  Priority="72"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful List" ></w:LsdException>
<w:LsdException Locked="false"  Priority="73"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Grid" ></w:LsdException>
<w:LsdException Locked="false"  Priority="60"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Shading Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="61"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light List Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="62"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Grid Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="63"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 1 Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="64"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 2 Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="65"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 1 Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  UnhideWhenUsed="false"  QFormat="true"  Name="List Paragraph" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Quote" ></w:LsdException>
<w:LsdException Locked="false"  Priority="99"  SemiHidden="false"  Name="Intense Quote" ></w:LsdException>
<w:LsdException Locked="false"  Priority="66"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 2 Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="67"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 1 Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="68"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 2 Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="69"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 3 Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="70"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Dark List Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="71"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Shading Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="72"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful List Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="73"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Grid Accent 1" ></w:LsdException>
<w:LsdException Locked="false"  Priority="60"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Shading Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="61"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light List Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="62"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Grid Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="63"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 1 Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="64"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 2 Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="65"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 1 Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="66"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 2 Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="67"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 1 Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="68"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 2 Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="69"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 3 Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="70"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Dark List Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="71"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Shading Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="72"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful List Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="73"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Grid Accent 2" ></w:LsdException>
<w:LsdException Locked="false"  Priority="60"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Shading Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="61"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light List Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="62"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Grid Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="63"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 1 Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="64"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 2 Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="65"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 1 Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="66"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 2 Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="67"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 1 Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="68"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 2 Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="69"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 3 Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="70"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Dark List Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="71"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Shading Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="72"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful List Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="73"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Grid Accent 3" ></w:LsdException>
<w:LsdException Locked="false"  Priority="60"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Shading Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="61"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light List Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="62"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Grid Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="63"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 1 Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="64"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 2 Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="65"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 1 Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="66"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 2 Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="67"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 1 Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="68"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 2 Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="69"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 3 Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="70"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Dark List Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="71"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Shading Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="72"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful List Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="73"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Grid Accent 4" ></w:LsdException>
<w:LsdException Locked="false"  Priority="60"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Shading Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="61"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light List Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="62"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Grid Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="63"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 1 Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="64"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 2 Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="65"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 1 Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="66"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 2 Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="67"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 1 Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="68"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 2 Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="69"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 3 Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="70"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Dark List Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="71"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Shading Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="72"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful List Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="73"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Grid Accent 5" ></w:LsdException>
<w:LsdException Locked="false"  Priority="60"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Shading Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="61"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light List Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="62"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Light Grid Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="63"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 1 Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="64"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Shading 2 Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="65"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 1 Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="66"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium List 2 Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="67"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 1 Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="68"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 2 Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="69"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Medium Grid 3 Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="70"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Dark List Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="71"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Shading Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="72"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful List Accent 6" ></w:LsdException>
<w:LsdException Locked="false"  Priority="73"  SemiHidden="false"  UnhideWhenUsed="false"  Name="Colorful Grid Accent 6" ></w:LsdException>
</w:LatentStyles></xml><![endif]--><style>
@font-face{
font-family:"Times New Roman";
}

@font-face{
font-family:"宋体";
}

@font-face{
font-family:"等线";
}

@font-face{
font-family:"Wingdings";
}

@font-face{
font-family:"Arial Narrow";
}

@font-face{
font-family:"黑体";
}

@font-face{
font-family:"微软雅黑";
}

@font-face{
font-family:"MS Gothic";
}

@list l0:level1{
mso-level-start-at:2;
mso-level-number-format:alpha-upper;
mso-level-suffix:none;
mso-level-text:"（%1）";
mso-level-tab-stop:none;
mso-level-number-position:left;
margin-left:0.0000pt;
text-indent:0.0000pt;
font-family:'Times New Roman';}

p.MsoNormal{
mso-style-name:正文;
mso-style-parent:"";
margin:0pt;
margin-bottom:.0001pt;
mso-pagination:none;
text-align:justify;
text-justify:inter-ideograph;
font-family:等线;
mso-bidi-font-family:'Times New Roman';
font-size:10.5000pt;
mso-font-kerning:1.0000pt;
}

h1{
mso-style-name:"标题 1";
mso-style-next:正文;
mso-margin-top-alt:auto;
mso-margin-bottom-alt:auto;
mso-pagination:none;
text-align:left;
mso-outline-level:1;
font-family:宋体;
mso-bidi-font-family:'Times New Roman';
mso-ansi-font-weight:bold;
font-size:24.0000pt;
mso-font-kerning:22.0000pt;
}

span.10{
font-family:'Times New Roman';
}

span.21{
font-family:'Times New Roman';
}

span.15{
font-family:'Times New Roman';
font-weight:bold;
}

span.16{
font-family:'Times New Roman';
font-size:9.0000pt;
}

span.17{
font-family:'Times New Roman';
color:rgb(149,79,114);
text-decoration:underline;
text-underline:single;
}

span.18{
font-family:'Times New Roman';
color:rgb(5,99,193);
text-decoration:underline;
text-underline:single;
}

span.19{
font-family:'Times New Roman';
font-size:10.5000pt;
}

span.20{
font-family:'Times New Roman';
font-size:9.0000pt;
}

span.22{
font-family:'Times New Roman';
font-size:9.0000pt;
}

p.MsoFooter{
mso-style-name:页脚;
mso-style-noshow:yes;
margin:0pt;
margin-bottom:.0001pt;
layout-grid-mode:char;
mso-pagination:none;
text-align:left;
font-family:等线;
mso-bidi-font-family:'Times New Roman';
font-size:9.0000pt;
mso-font-kerning:1.0000pt;
}

p.MsoCommentText{
mso-style-name:批注文字;
mso-style-noshow:yes;
margin:0pt;
margin-bottom:.0001pt;
mso-pagination:none;
text-align:left;
font-family:等线;
mso-bidi-font-family:'Times New Roman';
font-size:10.5000pt;
mso-font-kerning:1.0000pt;
}

p.MsoAcetate{
mso-style-name:批注框文本;
mso-style-noshow:yes;
margin:0pt;
margin-bottom:.0001pt;
mso-pagination:none;
text-align:justify;
text-justify:inter-ideograph;
font-family:等线;
mso-bidi-font-family:'Times New Roman';
font-size:9.0000pt;
mso-font-kerning:1.0000pt;
}

p.MsoHeader{
mso-style-name:页眉;
mso-style-noshow:yes;
margin:0pt;
margin-bottom:.0001pt;
border-bottom:1.0000pt solid windowtext;
mso-border-bottom-alt:0.7500pt solid windowtext;
padding:0pt 0pt 1pt 0pt ;
layout-grid-mode:char;
mso-pagination:none;
text-align:center;
font-family:等线;
mso-bidi-font-family:'Times New Roman';
font-size:9.0000pt;
mso-font-kerning:1.0000pt;
}

p.MsoCommentSubject{
mso-style-name:批注主题;
mso-style-noshow:yes;
mso-style-parent:批注文字;
mso-style-next:批注文字;
margin:0pt;
margin-bottom:.0001pt;
mso-pagination:none;
text-align:left;
font-family:等线;
mso-bidi-font-family:'Times New Roman';
font-weight:bold;
font-size:10.5000pt;
mso-font-kerning:1.0000pt;
}

p.28{
mso-style-name:"List Paragraph";
margin:0pt;
margin-bottom:.0001pt;
text-indent:21.0000pt;
mso-char-indent-count:2.0000;
mso-pagination:none;
text-align:justify;
text-justify:inter-ideograph;
font-family:等线;
mso-bidi-font-family:'Times New Roman';
font-size:10.5000pt;
mso-font-kerning:1.0000pt;
}

p.29{
mso-style-name:样式1;
margin:0pt;
margin-bottom:.0001pt;
mso-pagination:none;
text-align:left;
font-family:等线;
mso-bidi-font-family:'Times New Roman';
font-size:10.5000pt;
mso-font-kerning:1.0000pt;
}

span.msoIns{
mso-style-type:export-only;
mso-style-name:"";
text-decoration:underline;
text-underline:single;
color:blue;
}

span.msoDel{
mso-style-type:export-only;
mso-style-name:"";
text-decoration:line-through;
color:red;
}

table.MsoNormalTable{
mso-style-name:普通表格;
mso-style-parent:"";
mso-style-noshow:yes;
mso-tstyle-rowband-size:0;
mso-tstyle-colband-size:0;
mso-padding-alt:0.0000pt 5.4000pt 0.0000pt 5.4000pt;
mso-para-margin:0pt;
mso-para-margin-bottom:.0001pt;
mso-pagination:widow-orphan;
font-family:'Times New Roman';
font-size:10.0000pt;
mso-ansi-language:#0400;
mso-fareast-language:#0400;
mso-bidi-language:#0400;
}
@page{mso-page-border-surround-header:no;
	mso-page-border-surround-footer:no;}@page Section0{
margin-top:72.0000pt;
margin-bottom:72.0000pt;
margin-left:90.0000pt;
margin-right:90.0000pt;
size:595.3000pt 841.9000pt;
layout-grid:15.6000pt;
mso-header-margin:42.5500pt;
mso-footer-margin:49.6000pt;
mso-page-numbers:num-in-dash;
mso-title-page:yes;
mso-header:url("1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/header.html") h0;
mso-footer:url("1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/header.html") f0;
mso-first-footer:url("1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/header.html") ff0;
}
div.Section0{page:Section0;}</style></head><body style="tab-interval:21pt;text-justify-trim:punctuation;" ><!--StartFragment--><div class="Section0"  style="layout-grid:15.6000pt;" ><p class=MsoNormal  align=center  style="text-align:center;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:20.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >基于网络药理学的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:20.0000pt;mso-font-kerning:1.0000pt;" >TAMS</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:20.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >/</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:20.0000pt;mso-font-kerning:1.0000pt;" >CXCL-1验证是</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:20.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:20.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >预防乳腺癌发生和转移的关键介质</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:20.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;text-align:center;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >王能</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1，2</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >, </span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >郑轶枫</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >，</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >2，3</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >, </span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >古江勇</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >, </span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >蔡友丽</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >，</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >2</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >, </span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >王胜奇</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1，2，3</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >, </span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >张奉学</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >2</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >, </span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >陈建萍</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >4</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >, </span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >司徒红林</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1，2</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，林毅</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1，2</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，王志宇</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1，2，3</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;text-align:center;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >D</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(0,0,0);font-size:12.0000pt;
mso-font-kerning:1.0000pt;" >OI </span><span><a href="https://doi.org/10.1038/s41598-017-15030-3" ><u><span class="18"  style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(0,0,0);text-decoration:underline;
text-underline:single;font-size:12.0000pt;" ><font face="宋体" >https</font></span></u><u><span class="18"  style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(0,0,0);text-decoration:underline;
text-underline:single;font-size:12.0000pt;" >://doi.org/10.1038/s41598-017-15030-3</span></u></a></span><u><span class="18"  style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(0,0,0);text-decoration:underline;
text-underline:single;font-size:12.0000pt;" ><o:p></o:p></span></u></p><p class=MsoNormal  align=center  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;text-align:center;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(0,0,0);font-size:12.0000pt;
mso-font-kerning:1.0000pt;" >Scientific Reports ( IF 4.379 )</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(0,0,0);font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><b><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-weight:bold;font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >引言</font></span></b><b><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-weight:bold;font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></b></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >网络药理学已经成为了解中药在癌症治疗中作用机理的有力手段。这项研究旨在验证临床处方消癖颗粒</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对乳腺癌的预防作用和分子机制。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >体内乳腺癌异种移植数据显示，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >可以延</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >缓</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >乳腺癌的发展并有效抑制肺转移，并具有延长生存期和减少癌症干细胞亚群</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的作用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >但是，在细胞模型中未观察到类似现象。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中药成分靶向</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >网络分析进一步</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >确</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >定了总共</font>81个与</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的乳腺癌化</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >疗</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >预防作用密切相关的基因。细胞因子阵列分析进一步验证了</font>CXCL-1无论是在体内还是体外</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >都</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >作为</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的关键靶点。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对该机制的评估表明，</font>CXCL-1的</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >使用显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消除</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >了</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒对乳腺癌</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >转移、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >侵袭</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >干细胞亚群</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >上皮间质转</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >化</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>EMT）或乳腺</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >微</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >球形成能力的抑制作用。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >总的来说，我们的研究提供了实验证据和分子机制，可以促进安全有效地使用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中药</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >预防乳腺癌的生长或转移，并可能</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >发现</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >基于</font>CXCL-1的乳腺恶性肿瘤治疗策略。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;punctuation-trim:leading;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >乳腺癌是美国女性中最常见的恶性肿瘤，约占癌症的三分之一。据估计，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >2017年美国有乳腺癌病史的女性</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >将超过</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >280万</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。新</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >发</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >乳腺癌病例达到</font>255180</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >例</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，死亡高达</font>410702</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >例</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >2】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。乳腺癌还是全世界</font>184个</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >国家中就有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >140个</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >国家的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >女性被诊断出最常见的癌症之一</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。例如，在中国女性中，仅乳腺癌就</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >占</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >所有新发癌症的</font>15％。据估计，2015年，中国有272400例新</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >增</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >病例和</font>70700例乳腺癌死亡</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。从</font>2000年到2015年，中国的乳腺癌发病率</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >逐</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >步上升</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >4】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。寻找预防乳腺癌并</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >降低其死亡率的方法已成为世界范围内的紧迫问题</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >当前，乳腺癌的预防主要包括三种策略：改变生活方式，化学药物干预和手术干预。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >尽管饮酒、肥胖和激素替代治疗已被评估为乳腺癌的独立危险因素，但尚无针对饮食或体育锻炼的具体指南来专门预防乳腺癌</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >5】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。由于缺乏有力的证据和高质量的临床试验，因此生活方式</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的调整</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >仅</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >被推荐给</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >患者，作为临床环境中的补充措施。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >通过限制脂肪的摄入并每周进行</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >三至五次</font>30至45分钟的剧烈运动，鼓励女性保持理想的体重是合理的</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >6】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >化学</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药物干预指</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >逆转，抑制或抑制致癌转化的药理干预措施。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >选择性</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >雌激素调节</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >剂（</font>SERM</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >s</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）和芳香化酶抑制剂（</font>AIs）已被批准用于临床预防</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >7】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >他莫昔芬</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >可</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >将</font>ER阳性乳腺癌的风险降低62％，但不影响ER阴性乳腺癌</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >8】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >第二代</font>SERM雷洛昔芬</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >被</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >发现可将绝经后妇女的乳腺癌风险降低</font>44</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >-</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >76％</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >9】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。多项临床试验表明，</font>AIs可以降低绝经后女性患乳腺癌的风险。例如，已确认依西美坦可将患乳腺癌的风险降低65％，但是这些保护作用仅在ER阳性病例中</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >观察到</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >0</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >尽管在临床环境中建议将</font>SERMS和AIs用作化学预防</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药物</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，但它们的不良</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >反应</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >使他们的临床</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >应用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >出现问题。患者有子宫内膜癌</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中风</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >静脉血栓栓塞</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >肌肉骨骼疼痛</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >骨质疏松甚至骨折的风险</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >关于手术</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >干预</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，建议高危患者尤其是携带</font>BRCA1/2突变的患者进行双侧输卵管切除术和乳房切除术</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >2</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。大量回顾性研究和队列研究表明，预防性乳房切除术可以将患乳腺癌的风险降低</font>90％以上</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >5】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >但是，乳房切除术并不能完全消除乳腺癌的风险，因为</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >许多女性</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >不可能消除所有末梢小叶单位。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >此外，</font>8</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >-</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >64％的术后妇女经历一种或多种并发症，例如</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >出血，感染和皮瓣坏死</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >3</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。超过</font>30％的患者报告称，即使在进行了乳房再造后，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >她们也会对</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >乳房的外观感到尴尬</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，并且性唤起困难</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >4</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >因此</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >仍然有必要寻找新颖和安全的预防策略。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中药（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >TCM）在预防癌症方面具有独特的作用。在中医哲学中，癌症是由内源性身体状况和外源性致病因素引起的。身心</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >沟通系统</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的不和谐也可能引发癌症的发展</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >5</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。因此，中医将癌症视为一种全身性疾病，并着重于</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >整体</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >增强内部防御能力和恢复癌症的正常平衡，这与西医不同，后者仅侧重于杀死癌细胞。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中医因其五千年的悠久历史和成熟的理论方法在中国的农村地区和发达的城市受到赞赏。在台湾政府进行的一项横断面研究中，在</font>70012名女性乳腺癌患者中，有35.6％使用了TCM</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >6</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >一些</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >配方已被开发为商业产品，并应用于肿瘤缓解或稳定阶段。此类</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >治疗的例子包括康莱特注射液、复方苦参注射液、榄香烯乳剂注射液和金龙胶囊，它们在提高总生存率、降低毒性和预防疾病进展方面显示出良好的临床疗效</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >5</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >，</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >17</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >人们</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为了理解</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药在癌症预防和治疗中的治疗原理和分子靶点，已经付出了巨大的努力。据报道，许多中药配方或单一活性成分可通过调节</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >多种</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >分子靶标来抑制癌细胞生长</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >侵袭和转移的各种过程</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，包括</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >环氧合酶</font>2（COX-2），核因子</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >k</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >B（NF</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >-k</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >B）和核因子红</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >细胞</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >2相关因子（Nrf2）介导的抗氧化剂信号通路</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >等</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >8</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。但是，由于这些药物的复杂组成，大多数配方的基本机制仍不清楚，这意味</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >着其作用可能涉及多个靶标。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为了确定从分子水平到系统水平的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >TCM整体方法，在过去的几十年中已经开发了多种建设性技术。代表性的技术包括代谢组学，血清药代动力学，蛋白质组学和基因组阵列</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >1</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >9</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。这些方法倾向于将重点放在成分识别，药物代谢和靶标筛选上。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >需要一种更全面的方法来分析与</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药</font>-化合物-</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >靶</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >标网络相关的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >关系</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >近</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >年</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >来，系统生物学已经成为</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >一种</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >可以与药理学整合的新工具。系统药理学通过药代动力学评估（吸收，分布和代谢），靶标预测和网络分析为中药的整体概述研究做出了重大贡献</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >2</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >0</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。通过使用该方法，有可能将单一的</font><font face="宋体" >“一种药物，一种靶标”模型转变为更复杂的“药物-靶标网络相互作用”策略</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >2</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。同时，系统药理学大大加快了药物靶标筛选过程。通过结合疾病靶标数据库和分子验证，探索中药配方的精确分子靶标和机理变得越来越容易。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在本研究中，我们系统地探讨了临床应用上疗效显著的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒对乳腺癌的预防作用和机理。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >首先，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >转基因小鼠和体外细胞转化模型中对消癖颗粒的乳腺癌预防作用进行了验证。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >然后通过口服生物利用度和分子水平上的药物相似性评估发现了消癖颗粒中的活性成分。通过利用活性成分作为诱饵，我们预测了潜在的靶标</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >并在药理学水平上进一步构建了药物</font>-靶标之间的相互作用。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >后来我们使用细胞因子芯片分析确定</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >了</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CXCL-1为消癖颗粒的关键作用基因。我们进一步验证了CXCL-1在调</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >节</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒的抗癌作用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中的重要性（图</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >1）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >我们的工作突出了</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CXCL-1作为乳腺癌发展和消癖颗粒作用的关键靶点的作用，还有助于探索中医的潜在机制并促进其在复杂疾病治疗中的发展。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="text-align:center;line-height:150%;" ><img width="552"  height="490"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质08082870.png" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  align=center  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;text-align:center;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >图</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" >1.流程概述。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="mso-pagination:widow-orphan;text-align:center;" ><b><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;color:rgb(12,12,12);font-weight:bold;
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p>&nbsp;</o:p></span></b></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><b><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-weight:bold;font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p>&nbsp;</o:p></span></b></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><b><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-weight:bold;font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >材料和方法制备</font></span></b><b><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-weight:bold;font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></b></p><p class=MsoNormal  style="margin-top:5.0000pt;margin-bottom:5.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >消癖颗粒的制备</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒由</font>10种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药组成，包括淫羊</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >藿（学名：</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Epimedium brevicornuMaxim），肉</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >苁</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >蓉（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >学名：</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Cistanche </span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >D</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >eserticola ），益母草（</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >学名：</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Leonurus </span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >Heterophyllus</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >），丹参（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >学名</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >：</font>Salvia </span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >M</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >iltiorrhiza），</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >郁金</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >学名：</font><font face="宋体" >Curcuma Aromatica </font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >），</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >莪术</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >学名：</font><font face="宋体" >Rhizoma Curcumae）</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，女贞</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >子</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >学名：</font><font face="宋体" >Ligustrum Lucidum</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >），</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >制</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >何首乌（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >学名：</font><font face="宋体" >Radix Polygoni Multiflori Preparata</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >），</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >牡蛎</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >学名：</font><font face="宋体" >Crassostrea Gigas</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）和</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >鳖甲</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >学名：</font><font face="宋体" >Carapax Trionycis</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >将混合物超声处理</font>1小时，然后在100</span><span style="mso-spacerun:'yes';font-family:宋体;line-height:150%;
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >加热两次，每次</font>30分钟。通过旋转蒸发浓缩上清液，并在-80</span><span style="mso-spacerun:'yes';font-family:宋体;line-height:150%;
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >下保存过夜。然后将冷冻的上清液用冷冻干燥器处理</font>48小时，以找到粗制的水性提取物粉末。生产率为14.6</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >-</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >15.2％。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒水提取物的</font>HPLC分析在AQ-C18色谱柱（250mm&#183;4.6mm，5</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >&#956;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >m）上进行。流动相由（A）乙腈和（B）水组成，使用0-40分钟</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >梯度洗脱</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >5-20％A，40-50分钟的</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >梯度洗脱</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >20-30</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >％</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >A和50</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >-</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >80分钟的</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >梯度洗脱</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >30-95％A。溶剂流速为1.0mL/min，柱温为环境温度。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >结果表明，不同批次的</font>200nm处的化学指纹图一致（补充图1）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >将粉末溶解在磷酸盐缓冲溶液中，并通过</font>0.45</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >&#956;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >m的过滤器以备后用。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >乳腺癌异种移植物和乳腺整体镶嵌测定法</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >所有涉及动物实验的动物研究均经过香港大学伦理审查委员会的审查和批准。所有实验均按照香港实验动物管理局的指导方针和规定进行。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >采用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >转基因小鼠自发性乳腺癌发生模型，用于</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >观察</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒的癌症预防作用。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >将动物分为三组，包括野生型（</font>WT）组，MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >组和用消癖颗粒治疗</font>MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >小鼠组。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >自出生后第</font>4周开始，通过</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >灌胃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >以</font>0.5g/kg/d的剂量向MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >小鼠施用消癖颗粒。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >每三天记录一次肿瘤的数目，出现的时间，肿瘤的体积和体重。使用以下公式计算肿瘤体积：体积（</font>mm</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >3</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）</font>=宽度</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >2</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >*</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >长度</font>/2。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在实验结束时取出肿瘤组织，并进行组织学检查或流式细胞仪分析。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >计算肺转移结节</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >数</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >并在各组之间进行比较。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >切除</font>P</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >y</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >MT小鼠的乳腺，并如前所述分析了用胭脂红明矾染色的整个样本</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >4</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;mso-pagination:widow-orphan;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >特别</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >是</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，在尸检</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >时切出第四腹部乳腺，在载玻片上铺展</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >10min，并在Carnoy固定液（6份100％乙醇，3份氯仿和1份冰醋酸）中固定4h。随后，将</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >切片组织</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在</font>70％的乙醇中洗涤15分钟，然后将乙醇逐渐变为蒸馏水，最后在蒸馏水中漂洗5分钟。染色在胭脂红明矾中进行过夜。然后将</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >切片</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在梯度酒精溶液中脱水</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >70％，95％和100％每次30分钟）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >并</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >经过两次</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >二甲苯溶液</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >透明</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（每次</font>30分钟），</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >封片</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >并</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >使用封片胶（</font><font face="宋体" >Permount）</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >盖上</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >使用</font>SPOT FLEX彩色数码相机（Diagnostic</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Instruments，Inc。Sterling</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Heights，MI，美国）记录整个</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >切片制作过程</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><b><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-weight:bold;font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></b></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >细胞培养</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >人乳腺癌细胞</font>MDA-MB-231和MCF-7</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >细胞均购</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >自美国</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >菌种</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >保藏中心</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >ATCC</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >细胞培养在含</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >10%</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >胎牛血清（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >FBS</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）和</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >1％青霉素和链霉素（Gibco Life Technologies，Lofer，Austria）的培养基中（MDA-MB-231为L-15</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >培养基</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，</font>MCF-7为1640</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >培养基</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，所有细胞均在</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >37</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >5%CO</span><sub><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:sub;" >2</span></sub><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的培养箱中培养。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >将正常乳腺上皮细胞</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >MCF-10A在DMEM/F12中培养，辅以5%马血清、1%青霉素和链霉素、20ng/ml重组人表皮生长因子（EGF）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >0.5&#956;g/ml氢化可的松、100ng/ml霍乱毒素和10 &#956;g/ml胰岛素</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >将分类的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >MDA-MB-231癌症干细胞（CSCs）在补充有1%青霉素和链霉素，B27（Invitrogen，Carlsbad，CA，美国），20ng / ml hEGF（BD Bioscience，贝德福德，马萨诸塞州，美国），5&#956;g/ ml胰岛素和0.4%BSA的DMEM / F12培养基中进行体外繁殖，用于分子机制研究。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >流式细胞仪分析</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >洗涤缓冲液（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >PBS</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >洗涤小鼠原代乳腺细胞或乳腺癌细胞系（</font>MDA-MB-231和MCF-7），然后用胰蛋白酶收</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >集</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。用含有</font>1％FBS的洗涤缓冲液（PBS）洗涤分离的细胞，并悬</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >浮</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >于洗涤缓冲液（</font>10</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >6</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >细胞</font>/100</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >&#956;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >l）中。对于ALDEFLUOR分析，如前所述，使用基于醛脱氢酶的细胞检测试剂盒（法国格勒诺布尔的Stem</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Cell</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Technologies）进行实验。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >简而言之，将</font>2</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >×</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >10</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >5</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >个细胞悬浮在</font>Aldefluor&#174;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中含有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >ALDH底物（</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >Bo</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >dipy-Aminoacetaldehyde）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的测定缓冲液中，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >并在</font>37</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >下孵育</font>45分钟。作为参考</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对照</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在二乙氨基苯甲醛（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >DEAB），一种特定的ALDH1酶抑制剂</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >存在下，将细胞悬浮在含有</font><font face="宋体" >Aldefluor&#174;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >底物的缓冲液中。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >488nm蓝光激光检测荧光性ALDH1表达细胞（ALDH1</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >h</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >igh）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为了进行体外干细胞分析</font>/分选，将细胞与</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >从</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >BD Biosciences（美国圣地亚哥）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >获得</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的荧光</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >偶联</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的单克隆抗体</font>CD44-FITC和CD24-PE组合</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，在</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >4</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >于黑暗中孵育</font>40分钟，然后用PBS洗涤一次。FITC和PE标记的同种型IgG1作为阴性对照。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >免疫荧光测定</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >将</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >从体内研究获得的肿瘤样品固定在</font>4％多聚甲醛中，在70％乙醇中脱水，石蜡包埋，并切片（4</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >&#956;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >m）。为了进行免疫荧光分析，将石蜡包埋的肿瘤样品切片在二甲苯中脱蜡两次，每次10分钟，然后使用一系列梯度乙醇将其重新水</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >化。将切片和</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >4％聚甲醛固定的细胞用0.2％triton</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >X-100透化。在10％山羊血清中封闭1小时后，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >将载玻片与包括</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CD206、CD11b、ALDH1A3、E-钙粘蛋白和波形蛋白（ABclonal，Cambridge，MA，U.S.）在内的一级抗体在4</span><span style="mso-spacerun:'yes';font-family:宋体;line-height:150%;
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >下孵育过夜，然后荧光标记二级抗体（</font>SantaCruz，CA，US）在室温下放置2h。最后，将样品与DAPI孵育以进行核染色，并使用共聚焦显微镜检测信号。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >中药</font><font face="Arial Narrow" >-</font><font face="宋体" >成分</font><font face="Arial Narrow" >-</font><font face="宋体" >靶标相互作用分析</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >这些化学成分是从中医药数据库中收集的，包括中药系统药理学（</font>TCMSP）数据库（http://lsp.nwsuaf.edu.cn/tcmsp.php），中药综合数据库（TCMID，http：//www.megabionet.org/tcmid/）和BATMAN-TCM（</span><span><a href="http://bionet.ncpsb.org/batman-tcm/" ><u><span class="18"  style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;text-decoration:underline;text-underline:single;
font-size:12.0000pt;" >http://bionet.ncpsb.</span></u><u><span class="18"  style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;text-decoration:underline;text-underline:single;
font-size:12.0000pt;" ><o:p></o:p></span></u></a></span></p><p class=MsoNormal  style="line-height:150%;" ><u><span class="18"  style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;text-decoration:underline;text-underline:single;
font-size:12.0000pt;" >org/batman-tcm/</span></u><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >根据药物相似性（</font>DL）和口服生物利用度（OB）值筛选成分，如果DL</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >≥</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >0.18和OB</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >≥</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >30（TCMSP数据库建议的标准）则保留成分</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >4</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >2</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。具体</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >而言，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >ML的成分是DL值低的无机化合物。因此，没有按照这些标准进行筛选。使用Cytoscape软件（3.2.1版）为这些</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药构建了成分</font>-</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >靶</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >标网络。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >基因本体论和途径富集分析</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >从</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >GeneCards数据库（http://www.genecards.org/）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >收集与乳腺癌相关的靶点</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >数据集</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >GSE5764基于Afymetrix GeneChip&#174; Human Genome U133 Plus 2.0 Array平台，检索</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >来</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >自美国国家生物技术信息中心</font>(NCBI)基因表达综合(GEO)数据库(http://www.ncbi.nlm.nih).gov/geo)，然后由GEO2R(http://www.ncbi.</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >nlm.nih.gov/geo/geo2r/)分析。将差异表达的基因（DEG）提交给注释，可视化和综合发现数据库（DAVID；http：//david.abcc.ncifcrf.gov/）。根据基因本体论（GO）和《京都基因与基因组百科全书》（KEGG；http：//www.genome.jp</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >/kegg/kegg2.html），对DEG的显</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >富集分析进行了评估。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="position:absolute;z-index:1;margin-left:479.8000px;
margin-top:116.8000px;width:322.0000px;height:104.0000px;" ><img width="322"  height="104"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质08086264.png" ></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对于基因本体论（</font>GO）分析，它分为三类：分子功能，细胞成分和生物学过程。GO的基本单位是GO-term。每个GO术语都属于一种本体。GO富集分析提供了与基因组背景相比在DEG中明显富集的所有GO术语，并</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >筛选</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >了与生物学功能相对应的</font>DEG。首先，将所有DEG映射到Gene Ontology数据库（http://www.geneontology.org/）中的GO术语，计算每个术语的基因编号，通过超几何</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >学定义</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >DEG中与基因组背景相比显</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >富集的</font>GO术语测试。P值的计</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >算公式：</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >这里</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >N是所有带有GO注释的基因的数量；n是N中的DEG数；M是注释有特定GO术语的所有基因的数量；m是M中的DEG数。以FDR</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >≤</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >0.05为阈值，对计算出的P值进行了错误发现率（FDR）校正。满足此条件的GO术语被定义为DEG中</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >丰富的</font>GO术语。该分析能够识别DEG</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >s</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >行使的主要生物学功能。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >KEGG</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Pathway富集分析的计算公式与GO分析中的计算公式相同。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对于基因集富集分析（</font>GSEA），分析的3个主要步骤包括：富集得分（ES）的计算，ES</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >性水平的估算以及通过基于</font>GSEA</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >java软件的FDR计算进行的多假</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >设检验的调整</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >4</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >3</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >伤口愈合和</font><font face="Arial Narrow" >transwell</font><font face="宋体" >迁移测定</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为了进行伤口愈合测定，将</font>2×10</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >5</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >个细胞接种在</font>24孔板上。当它们完全融合时，用</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >带有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >10</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >&#956;l</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >MDA-MB-231移液管吸头</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在培养板中间制作了一个</font><font face="宋体" >“伤口”。在10倍物镜下，在刮擦后0h</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >12h或24h记录伤口愈合过程。伤口愈合率量化为伤口复原距离与原始伤口的距离。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >关于</font>transwell分析，transwell室（8</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >&#956;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >m，Milipore）用于细胞侵袭。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >底部腔室</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中加入</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >含有</font>10％FBS的培养基。将1×10</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >5</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >个细胞悬浮在无血清培养基中，并在有或没有药物处理的情况下铺在上室中。温</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >育</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >24小时后，使用棉签将细胞从上腔室中移出。渗透并附着在滤膜底部的细胞用4％甲醛的PBS溶液固定，然后0.5％结晶紫染色20分钟，然后在20倍物镜下成像。在三个独立的实验中</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;&nbsp;&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对入侵细胞的数量进行统计分析，并从五个图像场取平均值。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >细胞因子阵列分析</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >小鼠细胞因子抗体阵列</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >C2试剂盒购自RayBiotech（美国乔治亚州诺克罗斯）。补充图2列出了细胞因子的布局。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >简要地说，在</font>BM处理之前和之后，收集来自TAMs或小鼠血浆的细胞上清液。在室温下将抗体阵列膜在5％BSA中封闭30分钟后，将细胞上清液与抗体阵列在4</span><span style="mso-spacerun:'yes';font-family:宋体;line-height:150%;
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >下培养过夜，并洗涤</font>3次。然后将生物素化的抗体混合物与膜</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >一起温</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >育</font>2h，然后用HRP-链霉亲和素进行信号放大。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >最后，用购自</font>GE</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Healthcare（英国Buckinghamshire，UK）的ECL试剂盒</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >通过</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >化学发光法检测信号。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >实时</font><font face="Arial Narrow" >PCR</font><font face="宋体" >分析</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >使用</font>TRIzol试剂（Invitrogen，卡尔斯巴德，加利福尼亚州，美国）提取总RNA，然后使用第一链cDNA合成试剂盒（Roche，曼海姆，德国）进行逆转录反应。使用SYBR</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Green试剂盒（Roche，曼海姆，德国）在Roche</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >LightCycler 480检测器上进行实时</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >荧光定量</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >PCR分析。PCR反应条件设置如下：分别是95</span><span style="mso-spacerun:'yes';font-family:宋体;line-height:150%;
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >10分钟，95</span><span style="mso-spacerun:'yes';font-family:宋体;line-height:150%;
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >10秒，55</span><span style="mso-spacerun:'yes';font-family:宋体;line-height:150%;
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >30秒和72</span><span style="mso-spacerun:'yes';font-family:宋体;line-height:150%;
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >℃</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >1分钟</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，共</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >40个循环</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >使用</font>2</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >&#8722;&#916;&#916;</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Ct计算靶基因表达</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >并将其标准化为管家基因。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >引物的序列如下：</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >G-CSF（F，gctgctggagcagttgtg;R，gggatccccagagagtgg）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CCL-2（F，catccacgtgttggctca；R，gatcatcttgctggtgaatgagt）；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CXCL-2（F，aaaatcatccaaaagatactgaacaa</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >R，ctttggttcttccgttgagg）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CXCL-1（F，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >gact</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >ccagccacactccaac</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >R，tgacagcgcagctcattg）；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >GAPDH（F，aagagggatgctgccctta</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >R，ttgtctacgggacgaggaaa）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >统计分析</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >数据分析使用统计产品和服务解决方案（</font>SPSS）19.0软件进行。数据表示为平均值&#177;SD。t检验用于比较各组之间的统计学显</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >性差异。使用单向方差分析（</font>ANOVA），然后进行Dunnett检验，比较了多个组的显</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >性。</font>P＜0.05的值被认为是显</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:15.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><b><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-weight:bold;font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >结果</font></span></b><b><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-weight:bold;font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></b></p><p class=MsoNormal  style="margin-top:5.0000pt;margin-bottom:5.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >消癖颗粒可在体内抑制乳腺癌的发生</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为了</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >确认消癖颗粒的化学预防影响，我们首先使用</font>MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >转基因小鼠模型评估消癖颗粒在体内的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >有效性</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font>MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >转基因小鼠发展为自发性和管腔样乳腺癌。特别是，该模型最早可在</font>4周龄时检测到乳腺增生，并且在12-13周内将近100％的小鼠患上乳腺癌，并伴有肺转移的出现</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >2</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >2</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。因此，该模型通常用于评估乳腺癌的致癌机制或候选植物化学物质的化学预防作用。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >通过比较每组转基因小鼠每隔三天可触及病变的发生率，评估了</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒的抗癌活性。如图</font>2A所示，消癖颗粒处理</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >后乳腺肿瘤发生过程</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >明显受到限制</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在对照组中，肿瘤最早出现在第</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >4周，而在消癖颗粒干预下肿瘤延迟了一周（图2B）。值得注意的是，与</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对照</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >组相比，消癖颗粒组的肿瘤体积和数量受到了</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >抑制，进一步证实了该配方对乳腺癌的抑制作用（图</font>2C和D）。同时，消癖颗粒对小鼠体重的影响很小（图2E）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为了评估各组之间在乳腺致癌过程中的精确形态学变化，从各组小鼠收集第</font>4周至第8周的乳腺组织，并通过胭脂红染色分析进行比较。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >结果表明，野生型小鼠的导管长度</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >导管分支数量和末端数量随着年龄的增长而逐渐增加。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >但是，在</font>MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >转基因小鼠中，早在导管分支周围的第</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >4周就可以观察到增生性病变。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >直到第</font>5周，在消癖颗粒治疗组中均未发现病变。即使在第8周，癌前病变也明显小于对照组（图2F）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >这些发现表明，消癖颗粒可以有效地阻止乳腺组织的致癌转化。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="text-align:center;" ><img width="553"  height="534"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质08088679.png" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(255,0,0);font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  align=center  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;text-align:center;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >图</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" >2.消</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >癖颗粒延</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >缓</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >了体内乳腺癌的发作。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>A）对照组和消癖颗粒组中的代表性小鼠和肿瘤；消癖颗粒</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >给药可显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >抑制</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>B）乳腺癌的发作时间，（C）肿瘤体积（mm</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >3</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）和（</font>D）肿瘤数目，但对（E）小鼠体重的影响很小；（F）乳腺整体固定试验显示，MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >最早在第</font>4周发展为恶性病变，而消癖颗粒将恶性转化推迟至第5周。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:5.0000pt;margin-bottom:5.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >消癖颗粒可在体内抑制乳腺癌的肺转移和</font><font face="Arial Narrow" >CSCs</font><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >因为</font>MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >转基因小鼠模型具有在肺中形成转移灶的趋势，所以确定消癖颗粒是否可以抑制乳腺癌的肺转移是合理的。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >如图</font>3A所示，在实验期结束时，消癖颗粒组的转移性肺结节少于</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对照</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >组。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒处理的小鼠的存</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >活曲线显著长于对照组，后者在第</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >12周后显示出严重的死亡事件（图3B）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为了确定肺转移事件的减少是否与较少数量的癌症干细胞（</font>CSCs）相关，进行了ALDH</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >检测</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >以确认转移性病变中</font>CSC</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >s</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的数目。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >如图</font>3C所示，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对照</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >组中</font>ALDH1A3</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >呈</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >阳性的</font>CSC</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >s</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >高达</font>26.5&#177;2.3％，而消癖颗粒治疗组中只有5.5&#177;1.2％。免疫荧光分析进一步证实，消癖颗粒治疗组的ALDH1A3阳性CSCs</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >降低。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >更重要的是，长期服用消癖颗粒后，与</font>CSCs相关的</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >β</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >信号</font>-</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >连环蛋白的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >表达也受到抑制，进一步证明消癖颗粒可能通过</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >抑制</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CSCs抑制乳腺癌的肺转移（图3D）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="text-align:center;line-height:150%;" ><img width="515"  height="422"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质08089244.png" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  align=center  style="text-align:center;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >图</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >3.消癖颗粒可在体内抑制乳腺癌的肺转移</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(255,0,0);font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>A）对照组和消癖颗粒组肺转移病变的代表性图片；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>B）消癖颗粒可延长MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >生存期（</font>P=0.0056，其值表示为</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >平</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >均</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >值</font><font face="宋体" >&#177;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >SD，n=12）；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>C）消癖颗粒可抑制肺转移病变中的CSC</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >s</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >种群（</font>*P&lt;0.001，其值表示为</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >平</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >均值</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >&#177;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >SD，n=3）；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>D）消癖颗粒可抑制肺部ALDH</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >细胞的数量和</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >β</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >-catenin的表达。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >消癖颗粒在体外对乳腺癌细胞无明显抑制作用。</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >基于体内</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >试验</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >结果，探索消癖颗粒是否对乳腺癌细胞具有直接抑制作用是有趣且重要的。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >有趣的是，细胞增殖试验表明，消癖颗粒</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >0至600</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >&#956;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >g/ml范围内</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >MCF-7和MDA-MB-231乳腺癌细胞几乎没有抑制作用。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在</font>600至1000</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >&#956;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >g/ml的较高浓度下，消癖颗粒对MDA-MB-231的增殖具有抑制作用，但对MCF-7细胞的作用却很小。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒对正常乳腺上皮细胞系</font>MCF-10A几乎没有细胞毒性作用，证明了消癖颗粒体内治疗的安全性（图4A）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为了验证消癖颗粒对癌前细胞的潜在抑制作用，将癌基因</font>RAS转化为MCF-10A细胞。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >试验</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >结果证实，消癖颗粒对</font>RAS转化细胞的生存</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >活性</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >影响很小，表明消癖颗粒抑制乳腺癌的能力可能不归因于对癌症</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >细胞</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的直接毒性作用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（图</font><font face="宋体" >4</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >B</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >由于体内</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >试验</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >提示消癖颗粒可以抑制乳腺</font>CSC</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >s</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，因此有必要探讨消癖颗粒在体外系统中是否具有相似的作用。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >流式细胞仪检测表明，消癖颗粒对乳腺</font>CSCs细胞表面标志物CD44和CD24的分布影响很小，表明消癖颗粒对CSCs的抑制作用可能归因于肿瘤的微环境（图4C）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(255,0,0);font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="text-align:center;line-height:150%;" ><img width="531"  height="620"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质08089918.png" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  align=center  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;text-align:center;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >图</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" >4.消癖颗粒在体外对乳腺癌细胞增殖和CSCs群体影响不大。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>A）消癖颗粒对乳腺癌细胞MCF-7和正常乳腺上皮细胞MCF-10A的增殖抑制作用很小，但在800至1000</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >&#956;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >g/ml的高浓度下对MDA-MB-231有明显的毒性作用（**P&lt;0.01，以平均值&#177;SD表示的值，n=3）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>B）消癖颗粒对RAS转化的MCF-10A细胞的集落生长几乎没有抑制作用；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;mso-pagination:widow-orphan;
text-align:left;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>C）消癖颗粒对MDA-MB-231和MCF-7细胞中CSC的亚群大小几乎没有影响。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >推测消癖颗粒的主要成分和主要靶标。</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为所有</font>10种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药建立了成分</font>-</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >靶</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >标网络。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >结果表明，消癖颗粒的</font>10种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药产生了</font>105种成分，并进一步产生了806个潜在</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >靶</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >标（图</font>5）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对于每种</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >淫羊藿</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中有</font>23种化合物针对246个基因，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >肉苁蓉</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中有</font>6种化合物针对198个基因，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >女贞子</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >9种化合物针对215个基因，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >丹参</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >38种化合物针对115个基因，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >郁金中有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >3种化合物针对69个基因，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >莪术</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >3种化合物针对32个基因，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >益母草</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >8种化合物针对223个基因，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >制何首乌</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >6种化合物针对358个基因，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >牡蛎</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font>5种化合物靶向149个基因，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >鳖甲</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >4种化合物靶向182个基因（图5和补充表1）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="margin-top:16.0000pt;margin-bottom:8.0000pt;mso-pagination:widow-orphan;
text-align:center;mso-outline-level:3;background:rgb(255,255,255);" ><img width="553"  height="634"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质080810429.png" ><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;color:rgb(147,88,56);font-size:15.5000pt;
mso-font-kerning:0.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  align=center  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;text-align:center;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >图</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" >5.消癖颗粒中的10种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >药的成分</font>-</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >靶</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >标网络。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="margin-bottom:5.0000pt;text-align:center;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >菱形节点表示成分，圆形节点表示</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >靶</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >标。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >至少</font>4种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药的共同</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >靶</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >标如图</font>6A所示。在这些基因中，2个是9种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药的共同靶标，</font>9个是8种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药的共同靶标，</font>23个是7种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药的共同靶标，</font>30个是6种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >共同靶标，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >65个是5种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药的共同靶标，</font>69个是4种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药的共同靶标。（图</font>6B）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="text-align:center;line-height:150%;" ><img width="541"  height="258"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质080810588.png" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  align=center  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;text-align:center;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >图</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" >6.</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" >10种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >药的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >药</font>-靶标网络</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>A）10种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药</font>-靶标网络。菱形节点表示</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药，圆形节点表示</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >靶</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >标。分布在圆圈中的目标表示它们以相同数量的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药起作用，表示为</font><font face="宋体" >“n”；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;text-indent:21.0000pt;mso-char-indent-count:2.0000;
mso-list:l0 level1 lfo1;" ><![if !supportLists]><span style="font-family:宋体;mso-bidi-font-family:'Times New Roman';color:rgb(12,12,12);
font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><span style='mso-list:Ignore;' >（B）</span></span><![endif]><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >“</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药和</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >靶</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >标编号摘要</font><font face="宋体" >”的直方图。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为了鉴定影响乳腺癌进展的药物靶向基因，还从</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >GENECARDS数据库和GSE5764芯片组中提取了与乳腺癌相关的基因。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >如图</font>7A所示，通过GEO2R分析工具，GENECARDS中有1383个与乳腺癌相关的基因（A，相关性得分&gt;5），在GSE5764中有2609个经过验证的基因（B，P&lt;0.05）。Venn分析进一步证实三组之间共有81个基因重叠（补充表2）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对于</font><font face="宋体" >“基因本体论（GO）和途径</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >富集分析</font><font face="宋体" >”，需要适当的背景基因集来评估富集的显著性。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在这项研究中，从</font>a）所有</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >背景</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >基因或</font>b）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >a</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >和</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >b</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >之间的相交</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >基因</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >集合中选取了两个随机基因集作为背景基因。后者的目的是进一步研究富集是否由消癖颗粒组分的靶标驱动。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对于</font>GO术语分析（图7B），对81个基因的生物过程分析表明，除了突触前过程和</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >节律</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >过程外，两个背景上的富集都保持一致。值得注意的是，细胞成分分析</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >表明</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >细胞外基质区域</font>/部分区域与消癖颗粒作用最</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >相关。进一步的分子功能分析表明，两种背景中都存在的术语包括结合，催化活性，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >分子功能</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >/转导子活性，核酸结合转录因子活性，信号转导子活性，结构分子活性和转运蛋白活性。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对于</font>KEGG富集分析（图7C），结果表明两种背景中共存的81个基因的干扰途径主要负责支持癌症的生长和侵袭，如HIF-1信号传导，粘着斑信号传导，PI3</span><span style="mso-spacerun:'yes';font-family:'MS Gothic';line-height:150%;
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="MS Gothic" >&#8203;</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >K-Akt信号传导，Toll样受体信号传导，TNF信号传导，FoxO信号传导等。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >我们还进行了基因集（</font>GSE5764微阵列集）富集分析（GSEA），以揭示81个基因重叠是否</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >富集。</font>81个基因中有49个在策划的基因集（C2）中</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >富集，富集的途径为前列腺癌，多癌侵袭，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >增殖，侵袭性乳腺癌等。其中，有</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >34个基因在乳腺癌相关途径中</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >富集。此外，在</font>81个基因中，有39个基因</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >富集在</font>GO基因组（C5）中，富集的途径是细胞外基质</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >细胞外结构组织</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >表皮发育</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >外分泌系统发育等。细胞外结构组织的代表性分析如图</font>7D所示（ES=0.31937033，FDR&lt;0.01）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="text-align:center;line-height:150%;" ><img width="553"  height="306"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质080811525.png" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  align=center  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;text-align:center;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >图</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" >7.消癖颗粒中</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >靶点</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >的基因本体论（</font>GO）和途径富集分析。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>A）结合GENECARDS数据库A和GSE7564微阵列B，发现共有81个基因与消癖颗粒的抗乳腺癌活性密切相关；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>B）对81个基因的GO</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >-terms</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >分析，包含</font>3个方面，包括分子功能，细胞成分和生物学过程。选择a）所有背景基因或b）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >A</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >和</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >B</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >背景之间的相交基因分别评估</font>81种基因富集的重要性（微环境相关功能标有*）；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>C）81个基因的途径富集分析。选择a）所有基因背景或b）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >选择</font><font face="宋体" >A和B</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >背景之间的相交基因分别评估</font>81种基因富集的重要性；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >D）通过GSEA分析，细胞外结构组织的代表性分析如图7D所示（ES=0.31937033，FDR&lt;0.01</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >ClueGo WikiPathway分析（P&lt;0.05）还表明，消癖颗粒的</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >作用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >机制中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >涉及多种与癌症相关的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >通路</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，例如粘着斑</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >雌激素信号传导</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >通路、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Toll样受体信号传导</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >血管生成信号</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >通路、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >炎症反应途径和</font>AMPK</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >通路</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（图</font>8）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="text-align:center;" ><img width="553"  height="318"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质080811944.png" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(255,0,0);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  style="margin-bottom:5.0000pt;text-indent:23.7000pt;mso-char-indent-count:2.2600;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >图</font><font face="宋体" >8.通过ClueGo WikiPathway分析，对消癖颗粒的靶标进行功能分组网络分析（P&lt;0.05）。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >功能相关的组部分重叠，仅显示每个组中最重要的术语的标签。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(255,0,0);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >肿瘤微环境（</font><font face="宋体" >T</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >ME</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）是指肿瘤存活的细胞环境，包括周围的血管、免疫细胞、成纤维细胞、骨髓源性炎症细胞、淋巴细胞、信号分子和细胞外基质</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >2</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >3</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >-</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >25</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。有趣的是，</font>TME的定义恰好满足了上面预测的消癖颗粒影响信号的许多方面（*在图7B中指示），因此我们推测消癖颗粒可能通过微环境调节来预防乳</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >腺</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >癌的发生，这肯定需要下一部分进一步的实验验证。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >通过细胞因子阵列法鉴定</font><font face="Arial Narrow" >CXCL-1</font><font face="宋体" >是消癖颗粒的关键靶标。</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >基于网络药理学分析的结果以及肿瘤相关巨噬细胞（</font>TAMs）在癌症微环境中的关键作用</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >26</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，我们使用标记</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >物</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CD11b和CD206从MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >小鼠的实体瘤中筛选出</font>TAMs，然后用消癖颗粒处理TAMs（图9A）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >我们还从</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对照组</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >和消癖颗粒组的小鼠中收集了血浆。然后对血浆和</font>TAMs上清液进行细胞因子阵列分析。对照组和消癖颗粒治疗组之间</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >血浆细胞因子表达谱的比较</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >显示</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，消癖颗粒给药后有</font>8种细胞因子被下调，包括CCL11，G-CSF，IL-12p40/70，IL-12/p70，CCL2，CXCL-2，sTMFR1和TNF-</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >α</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，而癌症转移抑制基因</font>TIMP-1的表达，被消癖颗粒上调。关于TAMs上清液，发现消癖颗粒给药后6种细胞因子被下调，包括GM-CSF，G-CSF，CCL-2，CXCL-2，CXCL-1和RANTES。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >通过在体内和体外之间相交的细胞因子变化曲线，我们发现共有</font>4种细胞因子（G-CSF，CCL2，CXCL-2，CXCL-1）共享对消癖颗粒处理的相似变化响应（图9B）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >免疫荧光分析进一步验证了消癖颗粒组肿瘤中</font>TAMs的</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >强度降低，而且</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >qPCR证明，消癖颗粒处理均下调了所有4种细胞因子，CXCL-1显示出最明显的减少（图9C）</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="text-align:center;line-height:150%;" ><img width="553"  height="494"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质080812751.png" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p>&nbsp;</o:p></span></p><p class=MsoNormal  align=center  style="text-indent:21.0000pt;mso-char-indent-count:2.0000;text-align:center;
line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >图</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" >9.消癖颗粒针对的是TAMS/CXCL-1信号。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;color:rgb(12,12,12);font-size:10.5000pt;
mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:25.2000pt;mso-char-indent-count:2.4000;text-align:left;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>A）通过流式细胞</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >仪</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >从</font>MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >小鼠的肿瘤中分选出</font>TAM</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >s</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:25.2000pt;mso-char-indent-count:2.4000;text-align:left;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>B）细胞因子阵列鉴定出G-CSF，CCL2，CXCL-1/2是消癖颗粒在体外和体内系统之间的共同靶标；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:25.2000pt;mso-char-indent-count:2.4000;mso-pagination:widow-orphan;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >C</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >）免疫荧光分析发现，消癖颗粒施用后</font>TAMs密度显著降低，qPCR分析进一步证实CXCL-1是消癖颗粒施用后下调幅度最大的基因（*P&lt;0.05，**P&lt;0.01，值表示为平均值&#177;SD，n=3）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >消癖颗粒通过下调</font><font face="Arial Narrow" >TAM</font><font face="宋体" >分泌的</font><font face="Arial Narrow" >CXCL1</font><font face="宋体" >抑制乳腺癌转移</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >为了验证</font>CXCL-1</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >对</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒的抗癌活性的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >调节</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >作用，我们使用</font>MDA-MB-231细胞进行了体外验证实验。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >伤口愈合和</font>transwell分析表明，TAMs的上清液可以刺激细胞迁移并转移到载体处理过的细胞上。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >但是，消癖颗粒以剂量依赖的方式抑制</font>TAM诱导的细胞迁移。有趣的是，发现给予CXCL-1会加剧TAM的迁移刺激作用</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CXCL-1</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >抵消了</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒抑制转移的能力，表明</font>CXCL-1是负责</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >抗癌活性的关键介体（图</font>10A和B）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >免疫荧光分析还证明了</font></span><b><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-weight:bold;font-size:12.0000pt;
mso-font-kerning:1.0000pt;" >TAM</span></b><b><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-weight:bold;font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >上清液刺激</font><font face="宋体" >E</font></span></b><b><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-weight:bold;font-size:12.0000pt;
mso-font-kerning:1.0000pt;" >MT</span></b><b><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-weight:bold;font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >过程，</font><font face="宋体" >vimentin（波形蛋白）表达增加和</font></span></b><b><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-weight:bold;font-size:12.0000pt;
mso-font-kerning:1.0000pt;" >E-</span></b><b><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-weight:bold;font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >cad</font></span></b><b><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-weight:bold;font-size:12.0000pt;
mso-font-kerning:1.0000pt;" >herin</span></b><b><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-weight:bold;font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >（钙黏蛋白</font><font face="宋体" >E）</font></span></b><b><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-weight:bold;font-size:12.0000pt;
mso-font-kerning:1.0000pt;" ><font face="宋体" >水平降低。</font></span></b><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >相比之下，发现消癖颗粒可有效抑制</font>TAM诱导的EMT过程。更重要的是，还发现CXCL-1可以促进EMT转化并减轻消癖颗粒的生物活性（图10C）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >这些发现不仅表明</font>CXCL-1的转移促进作用与EMT机制密切相关，而且消癖颗粒的抗转移作用可能是通过抑制EMT过程来介导的。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >由于</font>EMT</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >过</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >程与</font>CSC</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >s</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的功能密切相关，因此我们进一步评估了它对</font>CSC</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >s</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的功能的影响。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >流式细胞仪分析表明，</font>TAM上清液可以增加CSC</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >s</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的数量，通过添加</font>CXCL-1</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >可以增强这种效果。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >但是，还发现</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒可以抑制</font>TAM处理后CSC群体的增加。同样，发现CXCL-1会削弱消癖颗粒的生物活性，这与我们上面给出的发现一致（图10D）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >乳</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >腺微</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >球测定还验证了</font>CXCL-1可以协助TAM上清液增加乳腺</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >微球</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的大小和数量，而消癖颗粒则抑制了它们的作用（图</font>10E）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >所有这些发现证明了</font>CXCL-1在介导消癖颗粒的癌症预防活性中的关键作用，并强调了CXCL-1在促进乳腺癌转移中的重要作用。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=center  style="margin-top:16.0000pt;margin-bottom:8.0000pt;mso-pagination:widow-orphan;
text-align:center;mso-outline-level:3;background:rgb(255,255,255);" ><img width="553"  height="461"  src="1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质0808.files/1、基于网络药理学的TAMSCXCL-1验证是消癖颗粒预防乳腺癌发生和转移的关键介质080813700.png" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >图</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >10.消癖颗粒通过CXCL-1抑制乳腺癌转移。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.4500pt;mso-char-indent-count:2.3300;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>A）伤口愈合试验消癖颗粒可以剂量依赖性地抑制MDA-MB-231迁移，但是CXCL-1处理</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >抵消了</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒的影响；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.4500pt;mso-char-indent-count:2.3300;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>B）Transwell分析表明消癖颗粒可以</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >抑制</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >MDA-MB-231细胞侵袭能力，CXCL-1给药恢复了该配方的抑制作用；</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.4500pt;mso-char-indent-count:2.3300;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >C）免疫荧光分析证实消癖颗粒可以</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >抑制</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >EMT过程，提示E-cadherin表达增加和波形蛋白水平降低，但CXCL-1过表达</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >能</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >逆转</font>EMT</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >被抑制的作用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.4500pt;mso-char-indent-count:2.3300;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font>D）流式细胞仪检测还表明消癖颗粒可以抑制CSC</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >亚群，但</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >TAMs上清液中CXCL1的</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >作用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >与消癖颗粒相反；</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:5.0000pt;text-indent:24.4500pt;mso-char-indent-count:2.3300;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >（</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >E）乳</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >腺微球</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >形成试验表明，乳</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >腺微</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >球的大小和数量</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >均受到消癖颗粒的抑制作用，但再次</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" >CXCL1给药后，乳</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >腺微</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
color:rgb(12,12,12);font-size:10.5000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >球的大小跟数量再次增加（</font>*P&lt;0.05，**P&lt;0.01，所有值均表示为平均值&#177;SD，n=3）。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><b><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-weight:bold;font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >讨论</font></span></b><b><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-weight:bold;font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></b></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >癌症是一种异质性疾病。它的启动不仅与促癌基因激活和抑癌基因失活有关，而且与异常的免疫功能、干细胞疾病和细胞因子失调密切相关</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >2</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >7</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >关于乳腺癌，据报道</font>BRCA1/2突变是遗传性乳腺癌发展的主要原因，相应的基因筛查已成为降低乳腺恶性肿瘤风险比的常规工具。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >然而，越来越多的证据表明，多种因素也有助于乳腺癌的发展，例如雌激素水平</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >雌激素受体状态</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >炎症，巨噬细胞活性</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >DNA修复能力以及mTOR生存信号的过度激活</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >2</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >8</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >，</font><font face="宋体" >2</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >9</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >乳腺癌的分子表型也会发生动态变化，例如亚型从</font>HER2阴性转变为阳性，癌症干细胞数量增加，淋巴细胞浸</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >润</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >0</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >因此，乳腺癌治疗已发展为包括外科手术</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >化学</font>/放射治疗</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >内分泌治疗和靶向治疗在内的多学科治疗。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >越来越多的人意识到，由于信号网络中存在代偿性反应，因此单靶标阻断策略无法消除癌细胞。这样，鸡尾酒策略或多</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >靶点</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >协议如今已引起了更多关注</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >1</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >巧合的是，</font>TCM因其多种化合物</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >多种</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >靶点</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >和多种途径而受到</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >重视</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。中医对某些不可治愈的疾病，包括自身免疫性疾病，慢性炎症和癌症，表现出神秘而深刻的治疗效果。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >在本研究中，我们证明了临床处方</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒可有效预防</font>MMTV-PyMT</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+/-</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >异种乳腺癌的进展。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >但是，它对乳腺癌细胞或</font>RAS转化的乳腺上皮细胞没有直接的抑制作用，这表明消癖颗粒的抗癌活性可能</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >与</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >系统调节</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >有关</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，尤其是对于肿瘤微环境</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的调节作用</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >由于消癖颗粒由</font>10种</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >中</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >药组成，其中可能包含数千种植物化学物质和分子靶标，因此当前的技术可能难以准确地解释其潜在机理。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >使用基于系统的策略阐明</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >的分子网络非常有趣。网络药理学最近成为一种强大的工具，可用于理解中药配方的复杂作用机制。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >通过数据库搜索和</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >网络分析，最终在</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒中鉴定出总共</font>105种活性化合物和806个基因。进一步的基因</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >交叉</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >分析确定了</font>81个基因与乳腺癌的发展密切相关。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >通过基因本体论和途径富集分析，发现了</font>81个基因</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >经验证可参与癌症发作期间的各种生物过程，例如对刺激的反应、免疫系统反应、细胞外信号、细胞器、结合活性以及粘着斑信号传导等。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >ClueGo WikiPathway分析显示，大多数信号传导均属于粘着斑</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Toll样受体信号转导</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >、</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >血管生成信号转导和炎症反应途径，进一步表明消癖颗粒</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >方</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >可能通过肿瘤微环境起作用。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >细胞因子阵列进一步表明，在体外和体内施用消癖颗粒均会影响多种细胞因子。在检测到的</font>32种细胞因子中，CXCL-1被证明是受该配方影响最深的细胞因子。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >其他研究也报道了生物信息学分析和网络药理学在乳腺癌中的应</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >用。</font><font face="宋体" >Cong </font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >F</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >u等人通过整合关于泛素介导的蛋白质半衰期的数据，建立了一个由文献挖掘的人类信号网络。他们的研究表明</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >26S蛋白酶体基因与乳腺癌的肿瘤进展和转移密切相关，并预测了乳腺癌患者的临床结局</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >2</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font>ZamanN等根据突变和拷贝数变异的信号网络评估，预测乳腺癌亚型特异性药物靶标</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >3</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font>McGee</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >&nbsp;</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >SR等揭示PIK3CA突变型乳腺癌中的阳性调节环，基于</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >癌症标志网络框架</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >预测了生存结果</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >4</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >综上所述，我们的工作通过整合生物信息学和网络药理学以及随后的实验验证，对乳腺癌预后标志物的发展具有重大意义。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CXCL-1是趋化因子家族CXC的成员，Richmond等首次报道它支持黑</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >色</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >素瘤的生长</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >5</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。最近的进展还表明</font>CXCL-1在多种恶性肿瘤中的关键作用。CXCL-1在乳腺癌细胞中的高表达可能将CD11b</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >&nbsp;</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >Gr1</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >+</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >&nbsp;</span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >髓样细胞吸引到肿瘤中，从而导致化学耐药性和转移</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >6</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。还发现</font>CXCL-1的过表达与胃癌的进展和不良的生存</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >率</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >密切相关。</font>CXCL-1</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >缺失</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >能够抑制胃癌细胞的迁移和侵袭能力</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >7</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。在膀胱癌中也证实了类似的发现。</font>CXCL-1水平在浸润性膀胱癌中显示出明显更高的水平，并能促进</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >肿瘤通过调节</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >MMP-13的表达进行转移</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >8</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >值得注意的是，发现</font>CXCL-1是从肿瘤基质细胞分泌的，并通过旁分泌信号传导影响癌症的进展。淋巴管内皮细胞分泌的CXCL-1可通过激活整联蛋白</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >β</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >1/FAK/AKT信号传导来促进胃癌的迁移，侵袭和粘附能力</span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >3</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >9</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >还发现</font>CXCL-1是肿瘤相关巨噬细胞分泌的一种细胞因子，该细胞募集了髓源</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >性</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >抑制细胞以形成转移前的</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >微环境</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >，并导致了大肠癌的肝转移</font></span><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >【</font><font face="宋体" >4</font></span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" >0</span></sup><sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;
vertical-align:super;" ><font face="宋体" >】</font></span></sup><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >当前的研究表明，</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >服</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >用消癖颗粒后，</font>TAMs的密度显</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >著</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >降低，并且在小鼠血浆和细胞上清液中</font>CXCL-1的水平也受到抑制。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >当</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CXCL-1细胞因子与消癖颗粒共同使用时，</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒的抗转移能力被阻断，提示</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CXCL-1可能是参与调节</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >消癖颗粒</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >作用网络的主要基因。</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="text-indent:24.0000pt;mso-char-indent-count:2.0000;line-height:150%;" ><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><font face="宋体" >综上所述，我们的研究提供了一种预防乳腺癌生长和转移的候选配方，并强调了</font></span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" >CXCL-1在介导消癖颗粒的生物活性中的作用。但是，仍需要进一步的研究来阐明CXCL-1在促进乳腺癌转移中的病理学意义，并通过高通量筛选技术从配方中鉴定出潜在的CXCL-1抑制剂。</span><span style="mso-spacerun:'yes';font-family:宋体;mso-bidi-font-family:'Times New Roman';
line-height:150%;font-size:12.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-top:7.0000pt;margin-bottom:7.0000pt;mso-pagination:widow-orphan;
text-align:left;mso-outline-level:2;line-height:150%;
background:rgb(255,255,255);" ><span style="mso-spacerun:'yes';font-family:宋体;mso-ascii-font-family:'Arial Narrow';
mso-hansi-font-family:'Arial Narrow';line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><font face="宋体" >参考文献</font></span><span style="mso-spacerun:'yes';font-family:'Arial Narrow';mso-fareast-font-family:宋体;
mso-bidi-font-family:宋体;line-height:150%;color:rgb(12,12,12);
font-size:15.0000pt;mso-font-kerning:0.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA: a cancer journal for clinicians 66, 7–30, https://doi.org/10.3322/caac.21332 (2016).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;text-align:left;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >DeSantis, C. E. et al. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA: a cancer journal for clinicians 66, 31–42, https://doi.org/10.3322/caac.21320 (2016).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Sinha, D., Biswas, J., Nabavi, S. M. & Bishayee, A. Tea phytochemicals for breast cancer prevention and intervention: From bench to bedside and beyond. Seminars in cancer biology, https://doi.org/10.1016/j.semcancer.2017.04.001 (2017).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >4 】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Zeng, H., Zheng, R., Zhang, S., Zou, X. & Chen, W. Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries. Journal of thoracic disease 6, 466–470, https://doi.org/10.3978/j.issn.2072-1439.2014.03.03(2014).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >5】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Euhus, D. M. & Diaz, J. Breast cancer prevention. Te breast journal 21, 76–81, https://doi.org/10.1111/tbj.12352 (2015).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >6】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Padamsee, T. J., Wills, C. E., Yee, L. D. & Paskett, E. D. Decision making for breast cancer prevention among women at elevated risk. Breast cancer research: BCR 19, 34, https://doi.org/10.1186/s13058-017-0826-5 (2017).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=left  style="text-align:justify;text-justify:distribute-all-lines;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >7】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Li, F., Dou, J., Wei, L., Li, S. & Liu, J. Te selective estrogen receptor modulators in breast cancer prevention. Cancer chemotherapy and pharmacology 77, 895–903, </span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;text-align:left;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >https://doi.org/10.1007/s00280-016-2959-0 (2016).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >8】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Fisher, B. et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute 90, 1371–1388 (1998).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >9】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Martino, S. et al. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. Journal of the National Cancer Institute 96, 1751–1761, https://doi.org/10.1093/jnci/djh319 (2004).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >0</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Goss, P. E. et al. Exemestane for breast-cancer prevention in postmenopausal women. Te New England journal of medicine 364, 2381–2391, https://doi.org/10.1056/NEJMoa1103507 (2011).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >1</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Cuzick, J. IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole. Expert review of anticancer therapy 8, 1377–1385, https://doi.org/10.1586/14737140.8.9.1377 (2008).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >2</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Heemskerk-Gerritsen, B. A., Kriege, M. & Seynaeve, C. Association of risk-reducing surgery with cancer risks and mortality in BRCA mutation carriers. Jama 304, 2695; author reply 2695–2696, https://doi.org/10.1001/jama.2010.1854 (2010).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >3</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Heemskerk-Gerritsen, B. A. et al. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. Annals of surgical oncology 14, 3335–3344, https://doi.org/10.1245/s10434-007-9449-x (2007).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >4</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Gopie, J. P. et al. Body image issues afer bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer. Familial cancer 12, 479–487, https://doi.org/10.1007/s10689-012-9588-5 (2013).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=left  style="text-align:justify;text-justify:distribute-all-lines;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >5</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Lin, H., Liu, J. & Zhang, Y. Developments in cancer prevention and treatment using </span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;text-align:left;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >traditional Chinese medicine. Frontiers of medicine 5, 127–133, https://doi.org/10.1007/s11684-011-0137-7 (2011).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >6</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Lin, Y. H. & Chiu, J. H. Use of Chinese medicine by women with breast cancer: a nationwide cross-sectional study in Taiwan. Complementary therapies in medicine 19, 137–143, https://doi.org/10.1016/j.ctim.2011.04.001 (2011).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;text-align:left;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >7</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Krishnaveni, M. & Mirunalini, S. Chemopreventive efcacy of Phyllanthus emblica L. (amla) fruit extract on 7,12-dimethylbenz(a)anthracene induced oral carcinogenesis–a dose-response study. Environmental toxicology and pharmacology 34, 801–810, https://doi.org/10.1016/j.etap.2012.09.006 (2012).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >8</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Liu, J. et al. Balancing Between Aging and Cancer: Molecular Genetics Meets Traditional Chinese Medicine. Journal of cellular biochemistry, https://doi.org/10.1002/jcb.25898 (2017).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >1</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >9</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Xu, T., Pi, Z., Liu, S., Song, F. & Liu, Z. Chemical Profiling Combined with “Omics” Technologies (CP-Omics): a Strategy to Understand the Compatibility Mechanisms and Simplify Herb Formulas in Traditional Chinese Medicines. Phytochemical analysis: PCA. https://doi.org/10.1002/pca.2685 (2017).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >0</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Li, S. & Zhang, B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chinese journal of natural medicines 11, 110–120, https://doi.org/10.1016/S1875-5364(13)60037-0 (2013).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >1</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Zhang, G. B., Li, Q. Y., Chen, Q. L. & Su, S. B. Network pharmacology: a new approach for chinese herbal medicine research. Evidence-based complementary and alternative medicine: eCAM 2013, 621423, https://doi.org/10.1155/2013/621423 (2013).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >2</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Lin, E. Y. et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Te American journal of pathology 163, 2113–2126, https://doi.org/10.1016/s0002-9440(10)63568-7(2003).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >3</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Joyce, J. A. & Fearon, D. T. T cell exclusion, immune privilege, and the tumor microenvironment. Science 348, 74–80, https://doi.org/10.1126/science.aaa6204 (2015).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >4</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Spill, F., Reynolds, D. S., Kamm, R. D. & Zaman, M. H. Impact of the physical microenvironment on tumor progression and metastasis. Current opinion in biotechnology 40, 41–48, https://doi.org/10.1016/j.copbio.2016.02.007 (2016).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >5</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Korneev, K. V. et al. TLR-signaling and proinfammatory cytokines as drivers of tumorigenesis. Cytokine 89, 127–135, https://doi.org/10.1016/j.cyto.2016.01.021 (2017).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >6</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Song, E. W. Te role of CCL18 signaling in breast tumor associated macrophages promoting cancer progression. Cancer Res 76, https://doi.org/10.1158/1538-7445.TUMMET15-IA24 (2016).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >7</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Yaguchi, T. & Kawakami, Y. Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation. International immunology 28, 393–399, https://doi.org/10.1093/intimm/dxw030 (2016).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >8</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E. & Gianni, L. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nature reviews. Clinical oncology 13, 674–690, https://doi.org/10.1038/nrclinonc.2016.66 (2016).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >2</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >9</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Krishnamurthy, A., Soundara, V. & Ramshankar, V. Preventive and Risk Reduction Strategies for Women at High Risk of Developing Breast Cancer: a Review. Asian Pacifc journal of cancer prevention: APJCP 17, 895–904 (2016).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >0</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Yuan, J. et al. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fbroblast-derived fbronectin and beta1-integrin signaling pathway in tumor cells. Breast cancer research: BCR 17, 69, https://doi.org/10.1186/s13058-015-0579-y(2015).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  align=left  style="text-align:justify;text-justify:distribute-all-lines;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >1</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Tao, L. et al. Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs. Pharmacological research 102, 123–131, </span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;text-align:left;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >https://doi.org/10.1016/j.phrs.2015.09.019 (2015).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >2</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Fu, C., Li, J. & Wang, E. Signaling network analysis of ubiquitin-mediated proteins suggests correlations between the 26S proteasome and tumor progression. Molecular bioSystems 5, 1809–1816, https://doi.org/10.1039/B905382D (2009).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;text-align:left;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >3</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Zaman, N. et al. Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specifc drug targets. Cell reports 5, 216–223, https://doi.org/10.1016/j.celrep.2013.08.028 (2013).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >4</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >McGee, S. R., Tibiche, C., Trifro, M. & Wang, E. Network Analysis Reveals A Signaling Regulatory Loop in the PIK3CA-mutated Breast Cancer Predicting Survival Outcome. Genomics, proteomics & bioinformatics 15, 121–129, https://doi.org/10.1016/j.gpb.2017.02.002 (2017).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >5</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Wang, D. et al. MGSA/GRO-mediated melanocyte transformation involves induction of Ras expression. Oncogene 19, 4647–4659, https://doi.org/10.1038/sj.onc.1203820 (2000).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >6</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Acharyya, S. et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 150, 165–178, https://doi.org/10.1016/j.cell.2012.04.042 (2012).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >7</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Cheng, W. L. et al. Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer. Annals of oncology: ofcial journal of the European Society for Medical Oncology 22, 2267–2276, https://doi.org/10.1093/annonc/mdq739 (2011).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >8</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Kawanishi, H. et al. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clinical cancer research: an ofcial journal of the American Association for Cancer Research 14, 2579–2587, https://doi.org/10.1158/1078-0432.CCR-07-1922 (2008).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >3</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >9</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Wang, Z. et al. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin beta1/FAK/AKT signaling. Cancer letters 385, 28–38, https://doi.org/10.1016/j.canlet.2016.10.043 (2017).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >4</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >0</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Miyake, M. et al. CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer. Neoplasia 18, 636–646, https://doi.org/10.1016/j.neo.2016.08.002 (2016).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >4</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >1</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Wang, N. et al. Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through WIF1 demethylation. Oncotarget 6, 9854–9876, https://doi.org/10.18632/oncotarget.3396 (2015).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >4</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >2</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Liu, H., Wang, J. N., Zhou, W., Wang, Y. H. & Yang, L. Systems approaches and polypharmacology for drug discovery from herbal medicines: An example using licorice. J Ethnopharmacol 146, 773–793, https://doi.org/10.1016/j.jep.2013.02.004 (2013).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p><p class=MsoNormal  style="margin-bottom:7.0000pt;line-height:110%;" ><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >【</font><font face="微软雅黑" >4</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >3</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><font face="微软雅黑" >】</font></span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" >Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profles. Proceedings of the National Academy of Sciences of the United States of America 102, 15545–15550, https://doi.org/10.1073/pnas.0506580102 (2005).</span><span style="mso-spacerun:'yes';font-family:微软雅黑;mso-bidi-font-family:'Times New Roman';
line-height:110%;font-size:9.0000pt;mso-font-kerning:1.0000pt;" ><o:p></o:p></span></p></div><!--EndFragment--></body></html>